Intraday BUY SELL Signals
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
BCAT vs CEFS
BCAT vs CEFS Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
BCAT vs. CEFS commentary
Feb 04, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAT is a Buy and CEFS is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
BCAT has more net assets: 1.61B vs. CEFS (375M). BCAT has a higher annual dividend yield than CEFS: BCAT (4.884) vs CEFS (1.040). BCAT was incepted earlier than CEFS: BCAT (5 years) vs CEFS (9 years). BCAT (1.99) has a lower expense ratio than CEFS (4.29). BCAT has a higher turnover CEFS (29.00) vs CEFS (29.00).
| BCAT | CEFS | BCAT / CEFS | |
| Gain YTD | 4.884 | 1.040 | 470% |
| Net Assets | 1.61B | 375M | 428% |
| Total Expense Ratio | 1.99 | 4.29 | 46% |
| Turnover | 257.00 | 29.00 | 886% |
| Yield | 2.36 | 6.59 | 36% |
| Fund Existence | 5 years | 9 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| BCAT | CEFS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | 1 day ago 71% |
| Stochastic ODDS (%) | 1 day ago 85% | 1 day ago 63% |
| Momentum ODDS (%) | 7 days ago 87% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 85% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 66% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 89% |
| Advances ODDS (%) | 13 days ago 83% | 7 days ago 88% |
| Declines ODDS (%) | N/A | 16 days ago 69% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 63% |
| Aroon ODDS (%) | 1 day ago 88% | 1 day ago 89% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BDHKX | 9.07 | -0.02 | -0.22% |
| BlackRock Dynamic High Income K | |||
| ANOCX | 15.75 | -0.07 | -0.44% |
| American Century Small Cap Growth C | |||
| JCVIX | 19.43 | -0.13 | -0.66% |
| JHancock Classic Value I | |||
| NELAX | 63.02 | -0.42 | -0.66% |
| Nuveen Equity Long/Short A | |||
| RGABX | 69.68 | -1.30 | -1.83% |
| American Funds Growth Fund of Amer R2 | |||
BCAT and
Correlation & Price change
A.I.dvisor tells us that BCAT and MSFT have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BCAT and MSFT's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To BCAT | 1D Price Change % | ||
|---|---|---|---|---|
| BCAT | 100% | -0.88% | ||
| MSFT - BCAT | 10% Poorly correlated | -2.87% | ||
| AMZN - BCAT | 3% Poorly correlated | -1.79% | ||
| MA - BCAT | 2% Poorly correlated | -0.84% | ||
| ASML - BCAT | 2% Poorly correlated | -3.16% | ||
| GOOG - BCAT | 2% Poorly correlated | -1.22% |